Pricing Log in Create free account

Serina Therapeutics, Inc. (SER) vs Tevogen Inc. (TVGN)

Serina Therapeutics, Inc. and Tevogen Inc. are both Biotechnology companies. Serina Therapeutics, Inc. and Tevogen Inc. are of similar size ($46.1M and $45.5M). Across the 8 metrics below, Tevogen Inc. leads on 5 and Serina Therapeutics, Inc. on 3.

Valuation

Metric SER TVGN Biotechnology median
P/E n/m n/m 8.50
P/S 160.23 n/m 9.71
P/B 1.55 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 66.04 n/m 9.21
Earnings yield (106.78%) (87.71%) (33.15%)
Free cash flow yield (73.10%) (42.97%) (25.50%)

Profitability

Metric SER TVGN Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (306.22%) 123.10% (56.36%)
Return on assets (136.00%) (492.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SER TVGN Biotechnology median
Revenue growth (TTM) (94.21%) — 6.02%
EPS growth (last fiscal year) (26.49%) (72.66%) 30.26%
Revenue growth, 5-year CAGR (18.48%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric SER TVGN Biotechnology median
Debt to equity 0.16 (0.72) 0.00
Current ratio 6.65 0.33 4.72
Net debt to EBITDA 0.00 (0.15) 0.96

Dividend

Metric SER TVGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SER TVGN Biotechnology median
Market cap 45.46m 46.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack